leonurine has been researched along with amyloid beta-peptides in 1 studies
| Studies (leonurine) | Trials (leonurine) | Recent Studies (post-2010) (leonurine) | Studies (amyloid beta-peptides) | Trials (amyloid beta-peptides) | Recent Studies (post-2010) (amyloid beta-peptides) |
|---|---|---|---|---|---|
| 130 | 1 | 110 | 3,257 | 48 | 1,626 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, ZY; Shi, XR; Wu, TT; Zhu, K; Zhu, YZ | 1 |
1 other study(ies) available for leonurine and amyloid beta-peptides
| Article | Year |
|---|---|
SCM-198 inhibits microglial overactivation and attenuates Aβ(1-40)-induced cognitive impairments in rats via JNK and NF-кB pathways.
Topics: Amyloid beta-Peptides; Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Cognition Disorders; Cytokines; Gallic Acid; L-Lactate Dehydrogenase; Male; MAP Kinase Kinase 4; Maze Learning; Microglia; Neurons; Neuroprotective Agents; NF-kappa B; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |